Skip to main content
. 2018 Oct 5;68(4):1376–1390. doi: 10.1002/hep.30035

Table 3.

Correlations between changes in HFF and modifications in clinical and metabolic parameters at follow up

HFF BMIZ SBP DBP Glu0 Ins CPEP Glu120 HBA1C WBISI IGI DI CholT HDL LDL TG VFAT SFAT ALT AST GGT ALP
HFF 1.000 0.193a ‐0.149 ‐0.071 ‐0.055 0.256b 0.168 0.069 0.139 ‐0.263b 0.160 ‐0.165 0.126 ‐0.197 0.153 0.117 0.284b 0.397d 0.369c 0.262b 0.183 0.232a
BMIZ 1.000 0.115 0.120 0.342 0.325c 0.183 0.149 0.438 ‐0.399d 0.285b ‐0.127 0.123 ‐0.147 0.186 0.028 0.210a 0.421d 0.230a 0.120 ‐0.094 0.145
SBP 1.000 0.563d 0.242b ‐0.017 0.320b 0.180 0.255a 0.050 0.084 0.092 ‐0.001 ‐0.073 0.007 0.045 ‐0.052 ‐0.071 0.070 0.235a 0.190 0.021
DBP 1.000 0.172 0.106 0.391c 0.159 0.035 ‐0.048 0.108 ‐0.027 ‐0.048 ‐0.193 0.016 0.014 ‐0.042 ‐0.079 0.061 0.068 0.416 0.058
GLU0 1.000 0.217a 0.213a 0.463d 0.178 ‐0.227a ‐0.077 ‐0.343c 0.161 ‐0.068 0.147 0.147 0.255b ‐0.052 0.046 0.094 0.525 0.018
INS 1.000 0.560d 0.367d 0.053 ‐0.811d 0.398d ‐0.463d 0.171 ‐0.029 0.146 0.121 0.070 0.264 b 0.248a 0.063 ‐0.265a 0.262a
CPEP 1.000 0.217a 0.059 ‐0.492d 0.391c ‐0.261a ‐0.044 ‐0.167 ‐0.074 0.104 ‐0.020 0.169 0.100 ‐0.022 ‐0.122 0.093
GLU120 1.000 0.200 ‐0.435d ‐0.052 ‐0.481d 0.098 ‐0.096 0.074 0.112 0.055 0.059 0.149 0.095 0.320 0.154
HBA1C 1.000 ‐0.036 0.091 ‐0.046 ‐0.070 ‐0.014 ‐0.104 0.064 ‐0.132 0.096 0.103 0.206 0.238 0.079
WBISI 1.000 ‐0.319c 0.566d ‐0.266b 0.183 ‐0.272b ‐0.229a ‐0.208a ‐0.377c ‐0.066 0.056 0.088 ‐0.272a
IGI 1.000 0.448d ‐0.094 ‐0.047 ‐0.003 ‐0.216a ‐0.120 0.128 ‐0.104 ‐0.176 ‐0.193 0.168
DI 1.000 ‐0.281b 0.044 ‐0.184 ‐0.309b ‐0.199a ‐0.193 ‐0.165 ‐0.055 ‐0.260 ‐0.148
CHOLT 1.000 0.352c 0.851 0.251a 0.156 0.137 0.234a 0.275b ‐0.004 0.057
HDL 1.000 0.135d ‐0.201a ‐0.343c ‐0.179 0.044 0.134 0.303 ‐0.062
LDL 1.000 ‐0.037 0.229a 0.255 a 0.174 0.229a 0.374 0.035
TG 1.000 0.210a ‐0.093 0.139 0.152 0.028 0.099
VFAT 1.000 0.432 d 0.071 0.108 ‐0.171 0.110
SFAT 1.000 0.219a 0.165 ‐0.141 0.097
ALT 1.000 0.760d 0.000 ‐0.038
AST 1.000 ‐0.018 0.017a
GGT 1.000 ‐0.284
ALP 1.000

Correlations between variables were assessed by Spearman correlations. a P<0.05; b P<0.01; c P<0.001; d P≤0.0001.

HFF%, hepatic fat fraction; BMIZ, body mass index z‐score; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; GLU0, plasma glucose at fasting; INS, plasma insulin at fasting; CPEP, plasma C peptide at fasting; GLU120, plasma glucose at 120 min (end of OGTT); HBA1C, hemoglobin A1c; WBISI, whole‐body insulin sensitivity index; IGI, insulinogenic index; DI, disposition index; CHOLT, total cholesterol; HDL, high‐density lipoprotein cholesterol; LDL, low‐density lipoprotein cholesterol; TG, triglycerides; VFAT, visceral fat; SFAT, subcutaneous fat; ALT, alanine transaminase; AST, aspartate transaminase; GGT, gamma‐glutamyl transferase; ALP, alkaline phosphatase.